NCT06562114View on ClinicalTrials.gov

A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions
Healthy
Interventions
DRUG

TML-6 Granules

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

91206

RECRUITING

Parexel International, Glendale

Sponsors
All Listed Sponsors
lead

Merry Life Biomedical Co., Ltd.

INDUSTRY

NCT06562114 - A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment | Biotech Hunter | Biotech Hunter